Costs of running a universal adolescent hepatitis B vaccination programme

L. A. Wallace*, D. Young, A. Brown, J. C. Cameron, S. Ahmed, R. Duff, W. F. Carman, N. R.E. Kitchin, Jonathan Nguyen-van-Tam, D. J. Goldberg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)


In the first UK study to examine feasibility and acceptability of universal adolescent hepatitis B vaccination, the costs associated with the administration and uptake (80.2 and 89.3% for three doses and at least two doses, respectively), of a three-dose regimen in pupils in Glasgow schools (2001/2002) were measured. These data were used to estimate the economic outlay for the delivery of a routine, ongoing three-dose and two-dose hepatitis B vaccine programme in schools. Vaccine, accounting for almost 70% of the overall costs, was the largest cost item for both the pilot and routine programmes, using either regimen. However, the ongoing, two-dose regimen was the cheapest option in this analysis, irrespective of vaccine price. Cost data from this study may be useful for other countries wishing to implement a similar programme.

Original languageEnglish
Pages (from-to)5624-5631
Number of pages8
Issue number48-49
Publication statusPublished - 1 Dec 2005

Bibliographical note

Funding Information:
We gratefully acknowledge the financial support from Aventis Pasteur MSD (now Sanofi Pasteur MSD).


  • Adolescent programme
  • Cost analysis
  • Hepatitis B vaccine


Dive into the research topics of 'Costs of running a universal adolescent hepatitis B vaccination programme'. Together they form a unique fingerprint.

Cite this